LIM Kinase inhibitor Pyr1 reduces the growth and metastatic load of breast cancers

Abstract : LIM kinases (LIMK) are emerging targets for cancer therapy, and they function as network hubs to coordinate actin and microtubule dynamics. When LIMKs are inhibited, actin microfilaments are disorganized and microtubules are stabilized. Owing to their stabilizing effect on microtubules, LIMK inhibitors may provide a therapeutic strategy to treat taxane-resistant cancers. In this study, we investigated the effect of LIMK inhibition on breast tumor development and on paclitaxel-resistant tumors, using a novel selective LIMK inhibitor termed Pyr1. Treatment of breast cancer cells, including paclitaxel-resistant cells, blocked their invasion and proliferation in vitro and their growth in vivo in tumor xenograft assays. The tumor-invasive properties of Pyr1 were investigated in vivo by intravital microscopy of tumor xenografts. A striking change of cell morphology was observed with a rounded phenotype arising in a subpopulation of cells, while other cells remained elongated. Notably, although Pyr1 decreased the motility of elongated cells, it increased the motility of rounded cells in the tumor. Pyr1 administration prevented the growth of metastasis but not their spread. Overall, our results provided a preclinical proof of concept concerning how a small-molecule inhibitor of LIMK may offer a strategy to treat taxane-resistant breast tumors and metastases. Cancer Res; 76(12); 3541-52. (c)2016 AACR
Document type :
Journal articles
Complete list of metadatas

Cited literature [63 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-01800008
Contributor : Lauriane Pillet <>
Submitted on : Tuesday, January 21, 2020 - 9:51:53 AM
Last modification on : Tuesday, January 21, 2020 - 11:04:04 AM

File

152479_2_merged_1460648662.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Chloé Prunier, Véronique Josserand, Julien Vollaire, Evelyne Beerling, Leanne Koning, et al.. LIM Kinase inhibitor Pyr1 reduces the growth and metastatic load of breast cancers. Cancer Research, American Association for Cancer Research, 2016, 76 (12), pp.3541-3552. ⟨10.1158/0008-5472.CAN-15-1864⟩. ⟨hal-01800008⟩

Share

Metrics

Record views

136

Files downloads

24